Forte BioSciences Inc(FBRX)

盘后76.500.000.00%17:05 EDT

76.50+21.72+39.65%

社区社区
资讯资讯
资料资料
公告公告

- 最新
- 推荐
公司概况
公司名称
Forte BioSciences Inc
所属市场
NASDAQ
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
http://www.fortebiorx.com
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
Forte Biosciences, Inc.是一家临床阶段的皮肤病学公司，致力于开发用于治疗炎症性皮肤病的活体生物疗法FB-401。 FB-401已完成对成人和儿童（3岁及以上）特应性皮炎患者的1/2a期测试。对于安全和有效的疗法，特别是对于小儿特应性皮炎患者，存在大量的需求。Forte计划在2020年代中期将FB-401推进到2期临床试验中。
- 07-16
  超过5%披露
  Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
  Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
- 07-09
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 07-08
  超过5%披露
  Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
  Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
- 06-08
  超过5%披露
  Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
  Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
- 06-02
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 06-02
  员工持股计划
  Form S-8 - Securities to be offered to employees in employee benefit plans
  Form S-8 - Securities to be offered to employees in employee benefit plans
- 05-15
  超过5%披露
  Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
  Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
- 05-15
  超过5%披露
  Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
  Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
- 05-15
  超过5%披露
  Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
  Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
- 05-15
  超过5%披露
  Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
  Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
- 05-15
  超过5%披露
  Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
  Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
- 05-14
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 05-14
  超过5%披露
  Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
  Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
- 05-13
  超过5%披露
  Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
  Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
- 05-11
  季度报告
  Form 10-Q - Quarterly report [Sections 13 or 15(d)]
  Form 10-Q - Quarterly report [Sections 13 or 15(d)]

分时
5日
日
周
月

数据加载中...

最高

76.60

今开

76.41

量比

25.89

最低

76.38

昨收

54.78

换手率

89.01%

Forte BioSciences Inc(FBRX)

公司概况

热议股票